Quisinostat dihydrochloride

Catalog No. A22453

Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally available, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity.
Catalog Num A22453
M. Wt 467.39
Formula C21H28Cl2N6O2
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 875320-31-3
Synonyms JNJ-26481585 dihydrochloride,JNJ26481585 dihydrochloride,JNJ 26481585 dihydrochloride
SMILES [H]Cl.O=C(C1=CN=C(N2CCC(CNCC3=CN(C)C4=C3C=CC=C4)CC2)N=C1)NO.[H]Cl
Quisinostat dihydrochloride (JNJ-26481585 dihydrochloride) is an orally available, potent pan-HDAC inhibitor with IC50s of 0.11 nM, 0.33 nM, 0.64 nM, 0.46 nM, and 0.37 nM for HDAC1, HDAC2, HDAC4, HDAC10 and HDAC11, respectively. Quisinostat dihydrochloride has a broad spectrum antitumoral activity.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 21.4 mL 106.98 mL 213.95 mL
0.5 mM 4.28 mL 21.4 mL 42.79 mL
1 mM 2.14 mL 10.7 mL 21.4 mL
5 mM 0.43 mL 2.14 mL 4.28 mL

*The above data is based on the productmolecular weight 467.39. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.